Where It Comes From
Dicofol (chlorobenzilate-related compound) was developed as a miticide (acaricide) in the 1950s as a compound related to DDT but with activity directed toward spider mites rather than insects. [1] It is synthesized from DDT through oxidation and has a structure nearly identical to DDT, differing only in that the trichloromethyl group of DDT is replaced by a trichloromethanol group (-CCl₂OH instead of -CHCl₂). This structural similarity means that early commercial dicofol was routinely contaminated with significant quantities of DDT itself — a contamination problem that EPA documented in the 1980s and required mitigation. [2] The primary crop applications are citrus, cotton, and various vegetables and ornamentals for two-spotted spider mite control. Like DDT, dicofol bioaccumulates in fatty tissues, is highly persistent in the environment (soil half-life years to decades), and is subject to long-range atmospheric transport — it has been found in Arctic and Antarctic wildlife and sediments far from any use area. EPA classified it as a probable human carcinogen based on rodent studies showing adrenal and liver tumors. [3] Its estrogenic and antiandrogenic endocrine disrupting properties are well-documented. The EU banned dicofol in 2008 under the persistent organic pollutants regulation; US registrations have been subject to ongoing review and restrictions. It is listed on the Stockholm Convention's candidate list for global elimination.
How You Are Exposed
Agricultural workers applying dicofol to citrus, cotton, and vegetable crops are the primary occupational exposure group. Consumers are exposed through dietary residues on treated food commodities. General population biomonitoring studies have detected dicofol in human blood and adipose tissue. Environmental background exposures occur from food and drinking water residues, and from the global atmospheric transport of this persistent compound.
Why It Matters
Dicofol combines the persistence and bioaccumulation of DDT with documented adrenal and liver carcinogenicity in rodents, and confirmed endocrine disruption — estrogenic activity at low concentrations can disrupt reproductive development in wildlife and potentially humans. [2] Studies on alligators in Florida's Lake Apopka — contaminated with dicofol — documented severe reproductive abnormalities including feminized male alligators, providing a famous case study of endocrine disruption in the environment. Aquatic organisms accumulate dicofol through food webs; bird reproduction is impaired at body burdens achievable through environmental exposure.
Who Is at Risk
Agricultural workers applying dicofol to citrus and cotton, and consumers who eat treated produce, are the primary exposure populations. Wildlife in and near treated agricultural areas, particularly predatory birds and fish-eating species, face ecological risks from bioaccumulation.
How to Lower Your Exposure
1. Support and purchase EU-certified produce, where dicofol has been banned. 2. Washing produce reduces surface residues; peeling citrus before eating removes further residues. 3. Agricultural applicators should use full PPE (chemical-resistant suit, gloves, face protection) and minimize spray drift. 4. Advocate for the transition to alternative acaricides with better environmental profiles for mite management. 5. Check for current US registration status, as it is subject to ongoing restrictions.
References
- [1][1] Tomlin CDS, ed. (2009). The Pesticide Manual. 15th ed. BCPC.
- [2][2] Colborn T, vom Saal FS, Soto AM (1993). Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives, 101(5), 378–384.
- [3][3] US EPA (1998). Dicofol: Reregistration Eligibility Decision. EPA 738-R-98-018.
Recovery & Clinical Information
Body Half-Life
Dicofol is highly lipophilic (log Kow ~5) and accumulates in adipose tissue. The biological half-life in human fat is estimated at months to years, similar to DDT-related compounds. It is metabolized to various chlorinated products including dichlorobenzophenone and further conjugates. Like DDT, it does not rapidly clear from the body once accumulated.
Testing & Biomarkers
Dicofol can be measured in human serum lipid or adipose tissue by GC-ECD or GC-MS/MS — the same methods used for DDT and other organochlorine pesticides in biomonitoring studies. CDC NHANES has measured dicofol in population surveys. Not routinely available from standard clinical labs; request from environmental or occupational toxicology specialists.
Interventions
No specific antidote or detoxification treatment for dicofol. Reducing further exposure (dietary changes, avoiding treated produce) is the primary action. Weight loss (which mobilizes fat stores) can temporarily increase blood dicofol concentrations as accumulated compound is released. For endocrine-related concerns, clinical evaluation of hormonal function is appropriate. Long-term exposure reduction through regulatory controls is the population-level intervention.
Recovery Timeline
Dicofol's very long half-life in fat tissue means body burden persists for years after cessation of dietary exposure. Complete elimination may take a decade or more. Cancer risk from past exposure does not reverse but does not increase after ending exposure.
Recovery References
- [1]EPA Reregistration Eligibility Decision: Dicofol (1998).
- [2]Colborn T, et al. (1993). Developmental effects of endocrine-disrupting chemicals. Environ Health Perspect, 101(5), 378–384.